Skip to main content
icon for ¿Casos de sarampión en EE. UU. antes del 31 de agosto?

¿Casos de sarampión en EE. UU. antes del 31 de agosto?

icon for ¿Casos de sarampión en EE. UU. antes del 31 de agosto?

¿Casos de sarampión en EE. UU. antes del 31 de agosto?

NUEVO
31 ago 2026
Polymarket

$5,512 Vol.

Polymarket

2400+

$581 Vol.

99%

2450+

$238 Vol.

99%

2500+

$417 Vol.

98%

2550+

$932 Vol.

93%

2600+

$3,344 Vol.

86%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing transmission across 47 U.S. jurisdictions, fueled by declining MMR vaccination coverage in multiple communities, drives elevated measles case counts through August 31. CDC data show 2,465 confirmed 2026 cases as of August 6, with 94% tied to 38 active or carryover outbreaks and 93% occurring among unvaccinated individuals. Measles’ high basic reproduction number sustains chains of infection once introduced, particularly in under-vaccinated clusters. Weekly CDC surveillance updates, typically released mid-week, provide the next authoritative tallies that could shift market-implied probabilities. Historical precedent indicates continued reporting from existing outbreaks is probable in the remaining three weeks, though exact increments depend on contact-tracing effectiveness and any localized public-health interventions.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$5,512
Fecha de finalización
31 ago 2026
Mercado abierto
Jul 31, 2026, 10:25 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing transmission across 47 U.S. jurisdictions, fueled by declining MMR vaccination coverage in multiple communities, drives elevated measles case counts through August 31. CDC data show 2,465 confirmed 2026 cases as of August 6, with 94% tied to 38 active or carryover outbreaks and 93% occurring among unvaccinated individuals. Measles’ high basic reproduction number sustains chains of infection once introduced, particularly in under-vaccinated clusters. Weekly CDC surveillance updates, typically released mid-week, provide the next authoritative tallies that could shift market-implied probabilities. Historical precedent indicates continued reporting from existing outbreaks is probable in the remaining three weeks, though exact increments depend on contact-tracing effectiveness and any localized public-health interventions.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$5,512
Fecha de finalización
31 ago 2026
Mercado abierto
Jul 31, 2026, 10:25 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Casos de sarampión en EE. UU. antes del 31 de agosto?" es un mercado de predicción en Polymarket con 5 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "2400+" con 99%, seguido de "2450+" con 99%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 99¢ implica que el mercado colectivamente asigna una probabilidad de 99% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

"¿Casos de sarampión en EE. UU. antes del 31 de agosto?" es un mercado recién creado en Polymarket, lanzado el Jul 31, 2026. Como mercado nuevo, esta es tu oportunidad de ser uno de los primeros operadores en establecer las probabilidades y las señales de precio iniciales del mercado. También puedes guardar esta página en marcadores para seguir el volumen y la actividad de trading a medida que el mercado gana tracción.

Para operar en "¿Casos de sarampión en EE. UU. antes del 31 de agosto?", explora los 5 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Casos de sarampión en EE. UU. antes del 31 de agosto?" es "2400+" con 99%, lo que significa que el mercado asigna una probabilidad de 99% a ese resultado. El siguiente resultado más cercano es "2450+" con 99%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Casos de sarampión en EE. UU. antes del 31 de agosto?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.